PHYSICOCHEMICAL AND PHARMACOKINETIC CHARACTERISTICS OF PLASMID DNA CATIONIC LIPOSOME COMPLEXES

被引:134
作者
MAHATO, RI [1 ]
KAWABATA, K [1 ]
NOMURA, T [1 ]
TAKAKURA, Y [1 ]
HASHIDA, M [1 ]
机构
[1] KYOTO UNIV,FAC PHARMACEUT SCI,DEPT DRUG DELIVERY RES,SAKYO KU,KYOTO 60601,JAPAN
关键词
D O I
10.1002/jps.2600841102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The objectives of this study were (i) to characterize the plasmid DNA encoding the chloramphenicol acetyltransferase reporter gene (pCAT) complexed with cationic liposomes (Lipofectin and LipofectACE) in terms of particle size and zeta potential, (ii) to compare pharmacokinetic characteristics, and (iii) to study the hepatic uptake mechanisms. DNA/LipofectACE complexes showed a negative zeta potential of -36 mV at 1:5 w/w ratio, but a positive zeta potential of 19 mV at 1:10 w/w ratio. Lipofectin samples showed a positive zeta potential of 21-28 mV at these ratios. These preparations showed a wide particle size distribution ranging from 600 to 1200 nm. Following intravenous injection of 1:10 w/w ratio [P-32]pCAT/liposome complexes at a dose of 0.1 mg DNA/kg into the tail vein of mice, radioactivity was rapidly eliminated from the plasma and almost 50-60% of the dose was taken up by the liver within 5 min after administration. Plasmid DNA/liposome complexes were predominantly taken up by the liver nonparenchymal cells. The hepatic uptake was inhibited by preceding administration of dextran sulfate (DS), but not by polycytidic acid (poly[C]) and polyinosinic acid (poly[I]), suggesting the involvement of a phagocytic process. We suggest that these complexes are preferentially taken up by the liver nonparenchymal cells mainly via Kupffer cell phagocytosis.
引用
收藏
页码:1267 / 1271
页数:5
相关论文
共 27 条
  • [1] BERTLING WM, 1991, BIOTECHNOL APPL BIOC, V13, P390
  • [2] EMLEN W, 1988, AM J PATHOL, V133, P54
  • [3] FELGNER P L, 1990, Advanced Drug Delivery Reviews, V5, P163, DOI 10.1016/0169-409X(90)90015-K
  • [4] PROGRESS TOWARD HUMAN-GENE THERAPY
    FRIEDMANN, T
    [J]. SCIENCE, 1989, 244 (4910) : 1275 - 1281
  • [5] CONTROL OF IN-VIVO FATE OF ALBUMIN DERIVATIVES UTILIZING COMBINED CHEMICAL MODIFICATION
    FUJITA, T
    NISHIKAWA, M
    OHTSUBO, Y
    OHNO, J
    TAKAKURA, Y
    SEZAKI, H
    HASHIDA, M
    [J]. JOURNAL OF DRUG TARGETING, 1994, 2 (02) : 157 - 165
  • [6] MODE OF FORMATION AND STRUCTURAL FEATURES OF DNA CATIONIC LIPOSOME COMPLEXES USED FOR TRANSFECTION
    GERSHON, H
    GHIRLANDO, R
    GUTTMAN, SB
    MINSKY, A
    [J]. BIOCHEMISTRY, 1993, 32 (28) : 7143 - 7151
  • [7] IMOTO H, 1992, CANCER RES, V52, P4396
  • [8] THE FATE OF PLASMID DNA AFTER INTRAVENOUS-INJECTION IN MICE - INVOLVEMENT OF SCAVENGER RECEPTORS IN ITS HEPATIC-UPTAKE
    KAWABATA, K
    TAKAKURA, Y
    HASHIDA, M
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (06) : 825 - 830
  • [9] KRIEGER M, 1993, J BIOL CHEM, V268, P4569
  • [10] DELIVERY OF PLASMID DNA INTO MAMMALIAN-CELL LINES USING PH-SENSITIVE LIPOSOMES - COMPARISON WITH CATIONIC LIPOSOMES
    LEGENDRE, JY
    SZOKA, FC
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (10) : 1235 - 1242